Amir Handzel PhD

Dr. Handzel is co-founder and CEO of Pangea Diagnostics, a start-up bringing the practice of pathology to the 21st century by automating the diagnostic process using deep machine learning and advanced image processing. He is also Principal at Quantum, a boutique consultancy in precision medicine. Previously Dr. Handzel served as Statistical Science Director at AstraZeneca where he was a member of its Precision Medicine & Genomics extended leadership team and a member of the team leading multi-drug, multi-party – Umbrella & Basket – clinical trials.

He had served as the head of the bioinformatics and biostatistics group at OSI Pharmaceuticals, a former subsidiary of Astellas Pharma, where he led the development of multivariate predictive biomarkers of drug efficacy for the oncology portfolio. He had also worked at Merck & Co. in the Biometrics Research department and at Beyond Genomics, a biotechnology company that specialized in broad profiling of high dimensional “omics” biomarkers. Dr. Handzel obtained his M.Sc. in Physics and Ph.D. in Applied Mathematics from the Weizmann Institute of Science and he conducted post-doctoral research at the Institute for Systems Research at the University of Maryland.